Management is buying/committing capital at a price it says the market itself just set against it — cheapness measured ag
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes deliberately taking on more of its own economic exposure because it believes the outside world is mispricing what it already has. The question asks: does management convey that outsiders are valuing the company or its assets at a level management considers plainly too low relative to something concrete and verifiable, AND that the company is responding by acquiring, retaining, or concentrating that exposure right now rather than shedding it? We need to look for both halves: (1) a mispricing claim anchored to something concrete, and (2) an action already in motion that increases the company's claim on that underpriced value. In the transcript, management talks about backlog, orders, growth, etc. They mention "we have the contracts in place to return to revenue growth in 2024 and expect growth of 20% or greater this year" and "our goal remains to become a more profitable company this year." They talk about "record order book" and "on-time in-full" improvements. They also mention "we are carefully selecting new strategic partners" and "opening the aperture to non-organic growth opportunities." They talk about "our qualified opportunity pipeline has grown exponentially" and "we expect several new customers, partners and project towards an announcements soon." But is there any mention of the company's shares or assets being undervalued? They don't mention share price, market cap, or any comparison to intrinsic value. They don't mention any buyback, insider buying, or any action to concentrate exposure. They talk about growth and backlog, but not about mispricing. They mention "we are fortunate to have world leading market making customers" and "we have a unique strategy that distances ourselves from commodity competition." But no concrete mispricing claim. They also mention "we took a really tough decision in Q4 to take those couple of days to realign the fabs so that we can grow." That's about production, not about buying assets. There is no mention of repurchasing shares, buying out partners, or any such action. They are not shedding exposure; they are growing, but that's not necessarily about mispricing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CTHR | Charles & Colvard, Ltd. | Q1 2023 | 2022-11-06 | F |
| SBGI | Sinclair Broadcast Group, Inc. | Q3 2022 | 2022-11-02 | C |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
TWO · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the mispricing to concrete, verifiable levels: mortgage spreads at “historically wide” levels (125–150 bp ZV/OAS, far above the non-QE average and the March 31 levels), RMBS coupons now trading at a wide range (2 %–5.5 %) with 300 bp “out-of-the-money” low-coupon pools and 97 bp OAS–ZV spread differential on higher-coupon names.
ESEA · Q4 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete, verifiable figure: their own estimate of the fleet’s market value at $666 million (derived from charter-adjusted values and market changes, incorporating the Aegean Express incident), which produces a net asset value of $344 million or >$48 per share.
WD · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete benchmark: CoStar trades at ~30x EBITDA while W&D trades at under 10x despite identical revenue and EBITDA growth rates over 5–10 years. They explicitly state there is “plenty of multiple expansion available to W&D.